Invesco CurrencyShares Swedish Krona Trust
Limited financial coverage for FXS.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
Price Chart
About the company
This investment product is specifically engineered to mirror the U. S. dollar value of the Swedish Krona.
- IPO
- 2009
Get TickerSpark's AI analysis on FXS
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- 52W High
- $2210.00
- 52W Low
- $94.48
- 50D MA
- $94.49
- 200D MA
- $94.49
- Beta
- -2.30
- Avg Volume
- 0
No earnings-call transcripts are available for FXS yet.
- Free Float
- 0.0%
- Shares Outstanding
- 150.82K
- Float Shares
- 0
Our FXS coverage
Recent articles, reports, and earnings notes.
No research on FXS yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate FXS report →Mirum Pharmaceuticals and Incyte Announce Positive Pivotal Phase 2 Results from PROGRESS Study of Zilurgisertib in Fibrodysplasia Ossificans Progressiva
gurufocus.com · Jun 14
Mirum Pharmaceuticals and Incyte Announce Pivotal Late-Breaking Results for Zilurgisertib in Fibrodysplasia Ossificans Progressiva Accepted for Presentation at ENDO 2026
gurufocus.com · Jun 4
Mirum Pharmaceuticals Announces New Data from Rare Liver Disease Programs Presented at the EASL International Liver Congress 2026
gurufocus.com · May 30
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.